ArticlePLoS computational biology2025
Inferring pathway activity from single-cell and spatial transcriptomics data with PaaSc.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Activation of ERBB4 Pathway Inhibits Pathological Transdifferentiation of Lung Epithelial Progenitors into CD66cAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Recent advances in single-cell and spatial transcriptomics have revolutionized our understanding of cellular heterogeneity. However, translating high-dimensional data into functional pathway insights remains challenging. To address this obstacle, we developed PaaSc (Pathway activity analysis of Single-cell), a computational method for inferring pathway activity at single-cell resolution. PaaSc employs multiple correspondence analysis to simultaneously project cells and genes into a common latent space and selects pathway-associated dimensions through linear regression to infer pathway activity scores. We validated PaaSc across diverse benchmarking datasets, including those that jointly profiled protein and RNA levels, as well as large-scale cancer scRNA-seq cohorts. Compared with state-of-the-art methods, PaaSc demonstrated superior performance in multiple applications: scoring cell type-specific gene sets, identifying cell senescence-associated pathways, and exploring GWAS trait-associated cell types. Importantly, PaaSc maintained accuracy despite batch effects and demonstrated robust performance across different data modalities, including scATAC-seq and spatial transcriptomics data. Our results demonstrate that PaaSc accurately captures dynamic cellular states and spatial patterns, thereby advancing our understanding of cellular dynamics, aging, and disease mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.